1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow capmatinib: new trials by email Literature Review of capmatinib trials Research Report on capmatinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC. Capmatinib 150 mg, Capmatinib 200 mg - Non-Small Cell Lung Carcinoma | Phase 4 | Completed | Novartis Pharmaceuticals | 50 | 2022-09-03 | 2026-10-26 |
Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1)
India (1)